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Ceramic materials are widely used for biomedical applications because of their remarkable biological and mechanical properties.
Compositesmade of alumina and zirconia are particularly interesting owing to their higher toughnesswith respect to themonolithic
materials. On this basis, the present study is focused on the in vivo behavior of alumina toughened zirconia (ATZ) dental implants
treated with a hydrothermal process. A minipig model was implemented to assess the bone healing through histology and mRNA
expression at different time points (8, 14, 28, and 56 days). The novel ATZ implant was compared to a titanium clinical standard.
The implants were analyzed in terms of microstructure and surface roughness before in vivo tests. The most interesting result deals
with a statistically significant higher digital histology index for ATZ implants with respect to titanium standard at 56 days, which
is an unprecedented finding, to the authors’ knowledge. Even if further investigations are needed before proposing the clinical use
in humans, the tested material proved to be a promising candidate among the possible ceramic dental implants.
1. Introduction
Titanium implants have the longest traceable record of
predictable clinical performance with very high success rate
[1]; however they are not without possible drawbacks [2]. In
fact, titaniummight be an allergen [3–5] and may diffuse not
only within the adjacent tissues, as it is proven by the elevated
concentrations found in the vicinity of oral implants [6] and
in regional lymph nodes [7], but also systemically [8]. As a
possible alternative to titanium, ceramic materials have been
already investigated and clinically used for years.
Alumina and yttria stabilized zirconia (Y-TZP) ceramics
are suitable for biomedical applications, due to their good
mechanical and tribological properties and proved biocom-
patibility [9–14]. Pure alumina has been widely used as
femoral heads because of its high wear resistance, but no
application requiring osseointegration has been implemented
to date due to its high inertness. As far as TZP is concerned,
it was initially employed to replace alumina in femoral heads
owing to its higher fracture toughness, but the high number
of failures led to reconsider its suitability in this field. Indeed,
depending on temperature, zirconia exists in three phases:
monocline, cubic, and tetragonal. Monocline phase is the
most stable at room temperature, even if its mechanical
properties are inferior to those of tetragonal phase, so that
the latter is preferred. However, tetragonal phase should be
stabilized to prevent tetragonal phase transformation [15].
Once the transformation occurs, the process continuously
proceeds from the surface to the bulk, resulting in a volu-
metric expansion followed by failure [15]. Even if zirconia
materials transform most rapidly at temperature ranging
between 200∘C and 300∘C, at low temperatures the process is
enhanced by the presence of water, available in vivo [15–22].
Zirconia stabilized materials are employed in orthopedics
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and dentistry, although in very low percentage with respect to
commercially pure titanium and titanium alloys (Ti6Al4V),
probably because of the unlucky history as femoral heads [23]
and the survival rate inferior to that of titanium implants [24].
To overcome the limits of both monolithic materials,
researchers have focused on the preparation of composites
made of alumina and zirconia [25–27], already successfully
applied as femoral heads [28, 29]. The advantages of these
oxidic composites owedmainly to the limited transition from
the tetragonal phase to the monocline one, which enhances
the mechanical performance [23], and to an increase of the
material toughness [30, 31]. The combination of alumina
and zirconia allows compensating the moderate toughness of
alumina and the ageing effect of zirconia. It has been shown
that, when the percentage of ZrO
2
is kept under the 22% wt
[32], ageing phenomena do not occur independently from the
grain size.
The mechanical stability is not the only requirement a
good implant material should possess, since bioactivity is
necessary to ensure proper osseointegration. When dealing
with bone bonding materials, bioactivity can be described as
the ability to grow bonelike apatite on the material surfaces
[33]. Apatite formation in simulated body fluid (SBF) is
preferentially induced whenever particular hydroxyl sites
are on the surface, which can be achieved through acidic
and/or alkali treatments [34]. Consistently, Faga et al. [35]
described the formation of acicular hydroxyapatite crystals
onto the surface of alumina toughened zirconia (ATZ) sam-
ples treated hydrothermally. Furthermore, alumina zirconia
ceramics may elicit slightly better biological responses than
the commercially pure titanium usually employed for dental
implants [36]. Ceramic materials are also very suitable for
aesthetic oral rehabilitations, which may be required when
dental implants are located in the anterior part of the mouth,
as it would preclude the dark shimmer of titanium implants
[37–39].
The aforementioned promising properties of ATZ treated
with phosphoric acids, in terms ofmechanical and bioactivity
features, prompted the authors to study the in vivo behaviour
of such material. For this purpose, implants made of ATZ
were placed within the bone of recipient animals, using a
titanium clinical standard for comparison since no papers on
this topic are present in literature. For sake of completeness,
fatigue tests were performed according to UNI EN ISO
14801:2008 standards and surface properties were studied.
Indeed, as load bearing medical devices, dental implants are
not suitable to clinical use if they present defects possibly
affecting their mechanical strength, which may lead to early
failure under the chewing load; suchmight be the case of large
porosities within ceramic bulk materials.
2. Material and Methods
2.1. Implants. Powders with high purity were used to pro-
duce the oxidic implants (Tosoh ZrO
2
-20wt %Al
2
O
3
, (TZ-
3Y20AB), as “ready to press” powders, so that no additional
mixing was required before pressing. Green samples were
obtained by linear pressuring at 80MPa followed by Cold
Isostatic Pressing under 200MPa. The optimized conditions
for sintering process were: heating 50∘C/h up to 700∘C,
dwelling for 2 h at 700∘C, and heating of 100∘C/h up to
temperature sintering of 1500∘C and dwelling for 2 h at
this temperature. Hardness, toughness, and strength of the
full dense material was measured on proper specimens, as
reported elsewhere by Faga et al. [35]. The materials were
then subjected to Computer Aided Manufacturing obtaining
one-piece dental implants of 11.5 × 4.25mm. The surface
treatment was obtained by hydrothermal cycles (patent num-
ber: TO2012A000029 and PCT/IB2013/050425). Implants
were then treated with phosphoric acid under hydrothermal
conditions with the purpose of inducing bioactivity [35]. As a
control, dental implants with TiUnite surface were purchased
from Nobel Biocare (Nobel Biocare Italia, Agrate Brianza,
Italy).
2.2. Microscopy. Microstructure was studied by means of a
Scanning Electron Microscope Zeiss EVO 50 with Energy
Dispersion Spectroscopy analyzer for elemental composition
detection.
2.3. Roughness. The surface roughness was measured by
using a noncontact profilometer, Talysurf CCI 3000A on the
screw. The tests were performed within an air-conditioned
laboratory, where temperature is kept at 20∘C, on a represen-
tative surface of 90mm2.
2.4. Mechanical Tests. Mechanical tests were run in triplicate
according to UNI EN ISO 14801:2008 by using a monoaxial
machine for both the dynamic and static tests (Italsigma,
Italy) equipped with a loading cell (max. load: 3 kN). In static
conditions, the speed was 0.2mm/minute, the preload: 2N.
Based on the ISO standards mentioned above, the static tests
aim to define the load to be applied when performing the
dynamic tests. Therefore, a value inferior to the 80% of 𝐹mean,
which is themean value of the static test strength (𝐹Max) of the
three samples, was applied to the samples for 5 × 106 cycles in
a sinusoidal way.Theminimal strength 𝐹min corresponded to
the 10% of the maximal strength 𝐹max (𝑅 = 0,1).
2.5. In Vivo Experiments
2.5.1. Experimental Design. The in vivo experiment was con-
ducted on 16 minipigs. Eight experimental implants per
animal were inserted in the right tibia: 4 hydrothermally
treated ATZ and 4 Nobel Ti-Unite (Nobel Biocare Italia,
Agrate Brianza, Italy). Four animals were sacrificed at 8,
14, 28, and 56 days after the implant placement. The tibias
were block-sectioned and subjected to histomorphometric (4
samples per animal) and biomolecular analysis (4 samples
per animal). Outcomes were analyzed in terms of new bone
apposition by a digital histology index (DHI) and RNA
profiling.
2.5.2. Animal. Sixteen adult minipigs (mean weight 65.94 kg
SD = 2.84) were used in the experiment (CISRA, Turin,
Italy). The minipigs were fed standard pelleted cereal food
and were given water ad libitum. The animals underwent
an acclimation period of 1 week prior to surgery. Abiding
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with Italian law, all animal experiments were approved by an
academic ethics committee.
2.5.3. Surgical Procedure. After preanesthetic sedation with
2% xylazine (Rompun 2%, Bayer, Milan, Italy; 2.3mg/kg) and
tiletamine/zolazepam (Zoletil 100-Virbac 20%, Laboratoires
Virbac, Carros, France; 6.3mg/kg), surgery was performed
under intubation anesthesia with isoflurane/halothane and
O
2
. The right hind leg was prepared in a standard sterile
fashion. After exposing the tibia, the implants were inserted
with a 40Ncm torque. Then, the flap was closed and the
surgical access sutured so as to completely cover the implants,
whose head reached the bone level. Each tibia received 8
implants: 4 ceramic ones and 4 titanium implants. Tibial
bone specimens were collected at this stage to determine
baseline (time 0) values for the RNA analysis. At the estab-
lished time points, animals were euthanized by preanesthesia
with 2% xylazine (Rompun 2%, Bayer) (2.2mg/kg) and
tiletamine/zolazepam (6.6mg/kg) and an intracardiac injec-
tion of embutramide, mebezonium iodide, and tetracaine
hydrochloride (70mg/kg). Finally, the tibias were exposed
and dissectedinto slices.
2.5.4. Expression of Osteogenic Markers. To protect the RNA,
all specimens (8, 14, 28, and 56 days) were placed in
RNA Later (Qiagen, Milan, Italy) and stored at −80∘C
until testing. Before the RNA purification (RNeasy Mini Kit
Quiagen, Valencia, CA, USA), the samples were disrupted
using a TissueRuptor. Total RNA was subjected to reverse
transcription (High Capacity cDNA RT Kit; Cat#: 4368814
Applied Biosystems, USA). The cDNA obtained underwent
real-time polymerase chain reaction (RT-PCR) using com-
mercially available primer/probe cocktails for Sus scrofa
(TaqMan Gene Expression Assays collagen, type I, alpha 1
assay ID: Ss03373340 m1; secreted protein, acidic, cysteine-
rich (osteonectin) assay ID: Ss03392006 m1; bone gamma-
carboxyglutamate (gla) protein assay ID: Ss03373655 s1; bone
morphogenetic protein 2 assay ID: Ss03373798 g1 Applied
Biosystems, USA), following the manufacturer’s protocol.
Glyceraldehyde 3-dehydrogenase (TaqMan Gene Expression
Assays, glyceraldehyde-3-phosphate dehydrogenase assay ID:
Ss03374854 g1Applied Biosystems, USA)was used as internal
control.
2.5.5. Histological Analysis of the Peri-Implant Bone. To eval-
uate the bone healing and remodeling, histologic analysis
was performed at 8, 14, 28, and 56 days after implant. After
block section of the implants along with the adjacent bone,
the specimens were fixed in 4% formalin for 24 hours and
decalcified for 3 to 4 weeks in a mixture of 50% formic acid
and 10% sodium citrate tribasic. While the implants were
removed, the peri-implant bone samples were embedded
with paraffin wax and cut into 3𝜇m thick sections, along
the longitudinal implant axis, using a motorized microtome.
Polylysine coated slides were used to enhance the adhesion of
the tissue section during staining procedures.Thehistological
structure of the peri-implant bone was assessed by traditional
haematoxylin and eosin staining and for optical microscopy.
The digital histology index (DHI) was manually determined
using an imaging computer software (Olympus Dot Slide
BX51) on the virtual histology slide. Briefly, on each virtual
slide, the newly formed bone was measured by tracing a line
at the interface between bone and implant within a given
length (a standard length of 4 cm was adopted). The ratio of
newly formed bone to the total bone-implant interface taken
into consideration was expressed as a percentage. The DHI
was measured on both sides of each slide. Two specimens per
time points per material were obtained and at least 10 slides
were made from each block sectioned histological sample.
In addition, morphometric parameters such as (1) presence
of necrotic or fibrous tissue and (2) amount of organized
grouped osteoclasts and osteoblasts, together with (3) blood
vessels and (4) de novo formed bone, were assessed by two
independent histologists.
2.5.6. Histomorphometrical Reconstruction. Forty serial sec-
tions, 3 𝜇m thick, were cut from the 56-day-paraffin-
embedded blocks and stained as described above. After-
wards, the slides were acquired by an automated microscope
to generate virtual colored slides, which were converted
into grey scale images so as to allow further image pro-
cessing. The three-dimensional reconstruction of the sam-
ples was performed using Amira 4.0, an advanced vol-
ume modeling software (TGS Template Graphics Software,
http://www.tgs.com). Three different volumes were delimi-
tated from the cortex to the medullar space and a percentage
of bone density was calculated based on a densitometric
analysis of the white voxels, the cortical bone being taken as
a reference (100%).
2.5.7. Statistical Analysis. Data from RT-PCR and DHI were
analysed by GraphPad Prism 5 (GraphPad Software Inc, La
Jolla, CA, USA). RT-PCR was independently repeated at
least three times (𝑛 = 3), on the samples derived from
peri-implant bone (𝑛 = 2 per material per time point).
As for the DHI, each specimen (𝑛 = 2 per material per
time point) generated at least 10 virtual histological slides.
Statistical analysis was performed by using the one-way
analysis of variance (ANOVA) with post hocDunnett’s test or
the Student’s 𝑡-test, as appropriate. A 𝑃 value of <0.001 was
considered significant.
3. Results
3.1. Morphology and Surface Analysis. The implant morphol-
ogy is reported in Figure 1 for titanium and ceramic implants,
respectively. As for the titanium implant (Figure 1(a)), only
the fixture was considered for the analysis. Its geometry
is represented by a set of threads, identical in each part
of the screw and placed at the same distance from each
other. Regarding the ceramic implant (Figure 1(b)), as it is
a one piece, fixture and abutment could not be separated.
The intrabony screw shows a series of threads, similar to
that observed for titanium implant, in the upper part (the
one closer to the abutment), while some threads having a
“cup profile” are present in the apical part. Such a geometry
was realized with the purpose to favor the osseointegration.
Indeed, during the implant placement, the geometry of
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Figure 1: Implant geometry. Note: SEM images were acquired at low magnification to depict the shape of the titanium implant (a) and the
alumina toughened zirconia implant (b).
Table 1: Static mechanical tests.
𝐹Max (N)
A-01 675.6
A-02 912.03
A-03 737.3
the threads does not allow a complete flowing of the removed
bone. It is supposed that the residual bone could act as
nucleation center for the following bone growth, so that the
osseointegration may be promoted.
A detail of the implant surfaces is reported in Figure 2.
The titanium exhibits some pores along the whole surface,
while the ceramic appears fully dense. The topography of the
implant surface is shown in Figure 3 (Titanium, (a); ATZ,
(b)). Sa values are 3.4 𝜇m and 5.4 𝜇m for titanium and ATZ
implants, respectively.
3.2. Mechanical Tests. As reported in the experimental sec-
tion, the static test has the aim to set the conditions for
dynamic tests. The results (Table 1) indicate a quite high
variability of the load to failure, typical for brittle materials
like ceramics. Indeed, ceramicmaterials generally fail because
of the presence of some defects, like pores, inclusions, micro-
cracks, and combinations. This kind of fracture mechanism
leads to a large distribution of the strength, considerably
higher than that of ductile materials, as metals and their
alloys. An index of the variability of the strengths is rep-
resented by the Weibull Modulus: the lower the modulus,
the higher the distribution. As for oxidic materials such as
alumina and zirconia, Weibull modulus is about 10, while for
ductilematerials it is one order ofmagnitude higher [40].The
results of dynamic tests are reported in Table 2. All the three
samples survived after five million cycles of fatigue solicita-
tions.Therefore ATZ implants were suited to undergo further
in vivo experiments as they met the UNI EN ISO 14801:2008
standards that are mandatory for allowing the human use.
3.3. Bone Markers. No significant difference could be
detected between ATZ and titanium at the time points taken
Table 2: Dynamic mechanical tests.
A-04 A-05 A-06
Flexural moment
(Nmm)
𝑀mean 586.7 566.2 567.1
𝑀dyn 480.0 463.3 464.0
𝑀max 1066.8 1029.5 1031.0
𝑀min 106.7 102.9 103.1
Compression
force (N)
𝐹mean 95.4 95.7 95.5
𝐹dyn 78.0 78.3 79.0
𝐹max 173.4 174.1 175.5
𝐹min 17.3 17.4 17.5
into consideration (8, 14, 28, and 56 days) for the bone
markers observed (collagen type I, osteonectin, osteocalcin,
and BMP-2) in peri-implant bone tissue (Figure 4).
3.4. Histological Analysis. Presence of osteoid at the bone-
implant interface was noted at the earliest (8 days) time
point whereas little or no interfacial unmineralized matrix
was seen at all other time points for both ATZ and titanium
hosting bones. Aminimal amount of necrotic osteocyteswere
noted only at 8 days in proximity to the implant surface in
both groups (Figure 5(a)), at the cortical bone level, probably
due to the transitory overheating during the implant site
preparation. The cellular remodeling of the bone fragments
was similar between the ATZ and titanium groups and
activity peaked at 8 days after implantation.
Both treatment and control groups showed a steady
increase in the overall digital histology index up to 56
days (Figure 6). The DHI values differed in a statistically
significant way between the ATZ and the titanium samples
at day 56 (ATZ = 53.3% ± 6.5, Ti = 35.3% ± 1.9). At the earlier
time points, no significant difference could be found (at 28
days: ATZ = 45.4% ± 4.5, Ti = 32.1% ± 6.4) (Figure 7).
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Figure 2: Implant surface morphology. Note: SEM images were acquired at high magnification to depict the surface morphology of the
titanium implant (a) and the alumina toughened zirconia implant (b).
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Figure 3: Implant topography. Note: Surface roughness of titanium (a) and alumina toughened zirconia (b) implants was determined and
graphically portrayed.
3.5. Histomorphometrical Reconstruction. The densitometric
analysis of the white voxels of the medial and the apical areas
of the samples concerning the 56th day is reported in Table 3.
A statistical significant difference between the medial area
values of ATZ and Ti was found (Student’s 𝑡-test 𝑃 < 0.001).
4. Discussion
There is still a huge concern about the long-term durability of
the Y-TZP (yttria-stabilized tetragonal zirconia polycrystal),
due to the low temperature degradation (LTD) of zirconia
[15–19], despite its excellent biological properties [30, 31]. In
the present study, alumina-zirconia composites were chosen
for manufacturing dental implants, based on their reported
mechanical performances superior to those of themonolithic
oxides [29, 41]. Unsurprisingly, the ATZ implants tested fol-
lowing the ISO standards that regulate dental implants under
static and dynamic load (UNI EN ISO 14801:2008) showed
satisfactory mechanical behavior. Thus, alumina toughened
zirconia appears as a viable alternative to yttria stabilized
zirconia, as its higher resistance to crack growth is durable
and may withstand the so called ageing process taking place
in aqueous environment. ATZ was selected for the in vivo
experiment portrayed in the present paper on the basis of
previous data dealingwith the bioactivity assessed as per Faga
et al. [35]. Indeed, only with a particular hydrothermal treat-
ment was it possible to achieve hydroxyapatite precipitation
Table 3: Histomorphometrical reconstruction: percentage of
medullar bone density showed as mean ± standard deviation.
Voxel density Medial area Apical area
Alumina toughened zirconia 52.4 ± 2.6% 24 ± 4.2%
Titanium 44.2 ± 3.1% 19 ± 4.5%
on the ATZ samples, which did not occur, for instance, on the
ZTA specimens [35].
At the end of the manufacturing process, the ATZ
implants were analysed by scanning electron microscopy
and submitted to profilometry for roughness evaluation,
before the placement into the recipient animals, adopting
a swine model previously described [42]. As a control, an
anodized titanium oxide layer (TiUnite) containing anatase
and rutile and endowed with a moderately rough porous
surface topography was selected [43]. The ATZ implants
showed an average roughness (Sa = 5.4𝜇m) higher than that
of the titanium implants (Sa = 3.4 𝜇m). Topography and
surface roughness are known to positively affect the healing
process [44–46]. Indeed, increasing the level of roughness
ameliorates osseointegration [47], as it was acknowledged in
a 2009 consensus statement [48].
Biomolecular, histological and histomorphometrical
analyses were used to examine the differences in the
healing and remodeling processes between the two different
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Figure 4: Expression of the osteogenic differentiationmarkers. Quantitative real-time polymerase chain reaction (RT-PCR) analysis of BMP-
2 (a), osteonectin (b), collagen type I (c), and osteocalcin (d) transcript level (𝑛 = 3 for each condition for each time point). One-way analysis
of variance (ANOVA) with post hoc Dunnett’s test was used to assess statistical significance.
200𝜇m
(a)
200𝜇m
(b)
Figure 5: Representative histological images of cortical bone at 8 days. Note: E&E stain showing sporadic necrotic lacunae within cortical
bone in proximity to the implant surface at 8 days (a) and healthy bone (b). This phenomenon occurred only at the earliest time point in a
few cases for both alumina toughened zirconia and titanium implants and may be due the preparation of the implant site by drilling.
implant materials. Four different time points were evaluated.
Representative of the early phase of healing were 8 and 14
days, while intermediate and mature bone healing were
reasonably foreseen at 28 and 56 days, respectively, based
on earlier experiments [49]. Interestingly, hydrothermally
treated ATZ implants showed a statistically significant higher
digital histology index than the titanium implants at 56
days, which is an unprecedented finding, to the authors’
knowledge. Consistently, the 3D image analysis used to
quantify the peri-implant bone at 56 days indicated the
presence of a bone matrix denser along the ATZ than the
titanium implants, particularly in the medial area.
Although ATZ is able to elicit a satisfying biological
response in vitro, even in absence of modifications and
when roughness is excluded by mirror polishing [50], no
significant difference between the anodized titanium surface
and the hydrothermally treated ATZ surface was detected
at the mRNA level. These data could appear contradictory.
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Figure 6: Representative histological images of DHI calculation. Representative samples of the virtual histological slides used to calculate
DHI at day 56 are reported for titanium (a, b) and alumina toughened zirconia (c, d) implants, respectively, at lower (a, c) and higher (b, d)
magnification.
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Figure 7: Digital Histology Index (DHI). Note: The DHI values differed in a statistically significant way (Student’s 𝑡-test 𝑃 < 0.001) between
the alumina toughened zirconia (ATZ) and the titanium samples at day 56 (ATZ = 53.3% ± 6.5, Ti = 35.3% ± 1.9). At 28 days no significant
difference could be found (ATZ = 45.4% ± 4.5, Ti = 32.1% ± 6.4).
However, the expression level of the investigated osteogenic
markers has been normalized between the two different
conditions, not taking into account the differences in the
total number of cells that are effectively recruited by the two
materials. Indeed, the amount of cells in the peri-implant area
may differ greatly between ATZ and titanium, even if the
osteogenic gene expression profile was similar in the bone
forming cells growing along either ATZ or titanium. Hence,
DHI was not merely dependent on the gene expression, but
it could rather be affected by other surface characteristics
8 BioMed Research International
more active on cell recruitment and proliferation than on
osteoinductive features.
Based on this study, further investigations are needed
before recommending the clinical use in humans, although
the testedmaterial proved to be a promising candidate among
the possible ceramic dental implants.
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